Genetic Testing for Severe Inherited Conditions
Carrier screening is a cornerstone of modern prenatal care, designed to identify individuals who carry pathogenic variants in genes associated with heritable conditions. Although carriers are usually asymptomatic, if both partners are carriers of the same autosomal recessive condition, there is a 25% risk with each pregnancy that the child will inherit the disorder. For X-linked conditions, female carriers may transmit the mutation to their children, with males typically being more severely affected.
The Comprehensive Carrier Screening Panel uses next-generation sequencing (NGS) to detect pathogenic variants in genes linked to a wide range of inherited diseases. The panel is informed by guidelines from the American College of Obstetricians and Gynecologists (ACOG), which recommend that included conditions have a clearly defined phenotype, significantly affect quality of life, cause cognitive or physical impairment, require medical or surgical intervention, present early in life, be diagnosable prenatally, and have a carrier frequency of at least 1 in 100.
This panel typically includes conditions such as cystic fibrosis, sickle cell disease, Tay-Sachs disease, spinal muscular atrophy (SMA), beta-thalassemia, fragile X syndrome, and hemophilia. Each of these conditions has distinct clinical implications, ranging from chronic lung and pancreatic disease in cystic fibrosis, to neurodegeneration in Tay-Sachs disease, to progressive muscle weakness in SMA, and impaired clotting in hemophilia. Carrier screening is recommended before conception or in early pregnancy, enabling couples to make informed reproductive choices and access options such as preimplantation genetic testing, prenatal diagnosis, or early interventions.
- Screening family members for Severe Inherited Conditions
- Identifies carriers of significant heritable disorders prior to conception or early in pregnancy
- Guides to reproductive decision-making and counseling
- Facilitates early planning for affected pregnancies
Positive: Pathogenic variant(s) detected; carrier status confirmed. In autosomal recessive conditions, risk to offspring depends on partner’s carrier status. In X-linked conditions, female carriers may transmit disease to male children.
Negative: No variants detected; residual carrier risk significantly reduced but not eliminated.
Negative (no pathogenic variants detected)
Whole blood, EDTA, alternatively Amniotic fluid by amniocentesis.
Stability
- Ambient: 3-5 days
- Refrigerated: 7 days
- Frozen: unacceptable
- Genet Med. 2021 Oct;23(10):2015. [PMID: 34285390]
- Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. [PMID: 34634131]
- Genet Med. 2022 May;24(5):1156-1157. [PMID: 35094930]
- J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3 [PMID: 27638987]